MediNatura™ Inc. Announces Agreement to Purchase Heel Inc.

Products and Services

MediNatura Inc LogoPHILADELPHIAMay 30, 2014 — MediNatura™ Incorporated, a Delaware Corporation headquartered in greaterPhiladelphia, today announced an agreement to purchase the Heel Group’s USA operations, which is expected to be completed in late August 2014. Completion of the stock transfer is subject to standard closing procedures.

Current Heel Inc. products will be available to USA distributors through August 2014, and to retailers and medical practitioners through December 2014.

“We remain committed to serving the needs of our practitioners, retailers and the many people that rely on these medicines, while providing outstanding customer service throughout this transition,” said Jocelyn Levesque, MediNatura’s vice president of sales, and director of sales for Heel Inc.

MediNatura’s line of over-the-counter (OTC) products will be available to distributors and retailers beginning January 1, 2015. The following retail brands will be reformulated: ClearLife™ (allergy), Reboost™ (cold/flu), WellMind™ (calming, focus) and BodyAnew™ Cleanse. All will be available in the same dosage forms and sizes as currently sold.

The OTC Heel products Traumeel* and Zeel* will be phased out and replaced with T-Relief™ and T-Relief Arthritis™ from MediNatura. These products will be available in the same dosage forms and sizes as were Traumeel and Zeel, and will feature all-natural active ingredients. The BHI line of products will remain unchanged.

“MediNatura is dedicated to manufacturing and distributing high quality, FDA-regulated products, just as we did as Heel Inc.,” said Scott Mitchell, MediNatura’s vice president of operations and director of operations for Heel Inc.

Heel’s OTC products currently sold exclusively to medical practitioners will be replaced by MediNatura’s OTC product line, most of which will be priced 40 percent lower than current products. OTC Heel brands with international trademarks will be discontinued, including: Traumeel, Neurexan, Zeel, Oculoheel, Luffeel, Sinusin, Vinceel, Nectadyn, Adrisin, Gripp Heel, Viburcol, Vertigoheel, Spascupreel, Engystol and Lymphomyosot.*

“We know people can improve their lives by making healthy lifestyle choices, healthy food choices and healthy medicine choices,” said Cliff Clive, CEO of Heel Inc., and founder and CEO of MediNatura. “MediNatura’s mission is to improve lives with medicines from nature.”

Visit www.medinatura.com to learn more.

Customers can contact 1.800.621.7644 with questions.

*Trademarks of Heel GmbH

About MediNatura™ Inc.

MediNatura™ Inc., a Delaware Corporation headquartered in greater Philadelphia, is a homeopathic pharmaceutical company that makes medicines from nature. For more information on MediNatura and their products, please visit www.medinatura.com.

Advertisement

Current Issue

Table of Contents

Advertisement

Trending Articles

PERQUE LLC introduces PERQUE DigestivAide™ Herbal Bitters.

ASHBURN, VA – PERQUE LLC announces the launch of PERQUE DigestivAide Herbal Bitters, a novel combination of angelica, burdock, dandelion, fennel, ginger, and yellow dock bitters to be taken before meals to stimulate appetite and promote healthy digestion. The...

Custom Publishing

Quantum Energy Effects on Cell Recovery Rates

Quantum Energy Effects on Cell Recovery Rates

Author: Robert Sheaff, PhD, and Ian Mitchell Abstract This study investigated whether quantum field exposure generated by Leela Quantum Bloc Technology influences cell recovery rates in human cell lines. A series of double-blind experiments were conducted using Human...

Quantum Fields and Frequency Medicine

RAZI BERRY Quantum Fields and Frequency Medicine A Conversation with Philipp Samor von Holtzendorff Fehling on Remote Quantum Technology and Human Performance Interest in frequency medicine and subtle energy technologies continues to grow...

Featured News

Allergy Research News Release

Allergy Research News Release

RAZI BERRY Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science Collaborative research led by ARG’s Medical Affairs and Scientific Advisory Board reinforces the company’s commitment to thyroid category...